143 related articles for article (PubMed ID: 2114953)
1. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.
Rubio TT
Diagn Microbiol Infect Dis; 1990; 13(2):153-5. PubMed ID: 2114953
[No Abstract] [Full Text] [Related]
2. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
[TBL] [Abstract][Full Text] [Related]
3. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.
LeBel M
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):316-24. PubMed ID: 1907546
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
Rubio TT; Shapiro C
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF).
Millar BC; Malnarcic CM; McCaughan J; Moore JE
Clin Respir J; 2020 Jan; 14(1):64-68. PubMed ID: 31663261
[No Abstract] [Full Text] [Related]
7. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
[TBL] [Abstract][Full Text] [Related]
8. Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
Vazquez C; Municio M; Corera M; Gaztelurrutia L; Sojo A; Vitoria JC
Acta Paediatr; 1993 Mar; 82(3):308-9. PubMed ID: 8495091
[No Abstract] [Full Text] [Related]
9. What have we learned about early treatment of Pseudomonas aeruginosa infection in infants and children with cystic fibrosis?
Saiman L; Cohen MB
Arch Pediatr Adolesc Med; 2011 Sep; 165(9):867-8. PubMed ID: 21893653
[No Abstract] [Full Text] [Related]
10. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and safety of ciprofloxacin in paediatric patients.
Black A; Redmond AO; Steen HJ; Oborska IT
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():25-9. PubMed ID: 2292542
[TBL] [Abstract][Full Text] [Related]
12. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
Marchetti F; Candusso M; Faraguna D; Assael BM
Lancet; 2002 Feb; 359(9306):626-7. PubMed ID: 11867141
[No Abstract] [Full Text] [Related]
13. Photosensitivity associated with ciprofloxacin use in adult patients with cystic fibrosis.
Burdge DR; Nakielna EM; Rabin HR
Antimicrob Agents Chemother; 1995 Mar; 39(3):793. PubMed ID: 7793897
[No Abstract] [Full Text] [Related]
14. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Jensen T; Pedersen SS; Nielsen CH; Høiby N; Koch C
J Antimicrob Chemother; 1987 Oct; 20(4):585-94. PubMed ID: 3479420
[TBL] [Abstract][Full Text] [Related]
15. Safety of ciprofloxacin in children with cystic fibrosis.
Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
[No Abstract] [Full Text] [Related]
16. Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
McKnight AJ; Shaw A; Goldsmith CE; Clarke L; Millar BC; McCaughan J; Elborn JS; Reid A; Moore JE
Br J Biomed Sci; 2005; 62(1):30-2. PubMed ID: 15816210
[No Abstract] [Full Text] [Related]
17. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group.
Richard DA; Nousia-Arvanitakis S; Sollich V; Hampel BJ; Sommerauer B; Schaad UB
Pediatr Infect Dis J; 1997 Jun; 16(6):572-8. PubMed ID: 9194107
[TBL] [Abstract][Full Text] [Related]
18. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
Alfaham M; Holt ME; Goodchild MC
Br Med J (Clin Res Ed); 1987 Sep; 295(6600):699. PubMed ID: 3117310
[No Abstract] [Full Text] [Related]
19. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
Al-Obaidi H; Kalgudi R; Zariwala MG
Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
[TBL] [Abstract][Full Text] [Related]
20. Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.
Phair JP; Tan JS; Watanakunakorn C; Schwab L; Sanders LW
Am J Dis Child; 1970 Jul; 120(1):22-5. PubMed ID: 4316325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
